Cutanea Life Sciences, Inc., a U.S. prescription dermatology company, announced the introduction of “Facing Forward™,” a new mobile application for patients who are prescribed Aktipak™ (erythromycin and benzoyl peroxide) Gel, 3%/5%,

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In